Has cancer cure been finally found? What is Dostarlimab? All you need to know

Published on Jun 08, 2022 10:50 AM IST
Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths, according to the World Health Organization (WHO).
In the first time in history, a small clinical trial in the United States showed 100% eradication of the cancer disease in patients.(Twitter/RutgersCancer)
In the first time in history, a small clinical trial in the United States showed 100% eradication of the cancer disease in patients.(Twitter/RutgersCancer)
Written by Manjiri Sachin Chitre | Edited by Poulomi Ghosh

In the first time in history, a small clinical trial in the United States showed 100% eradication of the cancer disease in patients at the Memorial Sloan Kettering Cancer Center in Manhattan. Although the trial was done on a small scale, it has raised hopes that the world may soon be able to get rid of the dreaded cancer disease.

Cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020, or nearly one in six deaths, according to the World Health Organization (WHO). In 2020, the most common cancers are breast (2.26 million cases), lung (2.21 million cases), colon and rectum (1.93 million cases), and prostate cancers (1.41 million cases).

Also read: Cancer increases risk of developing diabetes: Study

Here is all you need to know about the trial:

1. The trial included 18 cancer patients who took a drug called ‘Dostarlimab’ for around six months, and by the end of it, every one of them got rid of their tumours, reported the New York Times.

2. As per the NYT, the 18 patients had undergone various treatments before for cancer including chemotherapy, radiation, and invasive surgery. The patients had reportedly undergone the US trial expecting to have to go through other procedures in the next step. However, no further treatment was needed.

3. According to experts, the drug ‘Dostarlimab’ includes laboratory-produced molecules and acts as substitute antibodies in the human body. As per experts, cancer is undetectable by physical exam - proving that the drug could be a potential cure for the disease. Dr Luis A. Diaz J. of New York's Memorial Sloan Kettering Cancer Center said this was “the first time this has happened in the history of cancer,” reported ANI.

Also read: A carcinogen is an agent that can cause cancer. Here are the carcinogens one should be aware of

4. The patients took the drug Dostarlimab every three weeks for six months during the trial. Notably, all the patients were in the similar stages of cancer and had not spread to other organs.

5. According to experts, the trial has been “shocking” and “unheard of”. Oncologist Dr Andrea Cercek described the moment patients found out they were cancer-free: “There were a lot of happy tears”, she said, as quoted by the NYT.

SHARE THIS ARTICLE ON
Topics
Close Story
QUICKREADS

Less time to read?

Try Quickreads

  • A health care worker prepares a dose of Imvanex, a vaccine to protect against Monkeypox virus.

    White people get bigger share of monkeypox shots, early data show

    Much like with Covid-19, the monkeypox health crisis in the US is hitting Black and Hispanic Americans hard. Yet those groups are so far lagging in vaccination rates, early data obtained by Bloomberg News show. In some major US cities with outbreaks, White people are getting the majority of vaccinations, data collected by Bloomberg show. In Chicago, 55% of vaccines have gone to White people. In Washington, D.C., 63.5% of vaccine recipients identify as White.

  • Sheikh Rahimullah Haqqani was killed in an attack in a seminary in Kabul.

    Top Taliban cleric killed in blast in Kabul: Officials

    A prominent Taliban cleric, Sheikh Rahimullah Haqqani, was killed in an attack in a seminary in Kabul when the attacker detonated explosives hidden in a plastic artificial leg on Thursday, according to officials and Taliban sources. It was not immediately clear who was behind the blast. Four Taliban sources told Reuters the attacker was someone who had previously lost his leg and had hidden the explosives in a plastic artificial leg.

  • The Chinese action came less than a month after Beijing blocked a similar joint proposal by India and the US to blacklist Pakistan-based deputy leader of Lashkar-e-Taiba Abdul Rehman Makki. (REUTERS)

    China says it needs more time to assess US, India proposal to blacklist JeM chief’s brother at UNSC

    China on Thursday said it needs more time to “assess” the India-US proposal to list Pakistan-based Jaish-e-Mohammed (JeM) leader Abdul Rauf Azhar as a global terrorist at the UN Security Council, hours after blocking the joint effort. Chinese foreign ministry spokesperson Wang Wenbin said the 1267 Committee of the UN Security Council has clear provisions about designating terrorist organisations and officials. China had similarly sought time to assess the case.

  • Chinese foreign minister Wang Yi speaks during a press conference on the sidelines of the East Asia Summit Foreign Ministers' Meeting in Phnom Penh on August 5, 2022. (AFP)

    China, Nepal agree on cross-Himalayan railway

    China has agreed to finance a feasibility study for a cross-border railway with Nepal under the trans-Himalayan multi-dimensional connectivity network, part of the Belt and Road Initiative and pledged $118 million for China-assisted projects in the country, the foreign ministries of the two countries have said. Chinese state councillor and foreign minister, Wang Yi said China will work with Nepal on power projects and also in building cross Himalayan connectivity projects.

  • File photo of Sri Lanka's then president, Gotabaya Rajapaksa.

    Sri Lanka's ex-leader Gotabaya Rajapaksa leaves Singapore: Report

    Former Sri Lankan President Gotabaya Rajapaksa left Singapore Thursday, the city-state's immigration office said, after his social visit pass expired. "The Immigration & Checkpoints Authority confirms that Mr Gotabaya Rajapaksa left Singapore on 11 August 2022," the office said in reply to an AFP query. Rajapaksa fled to the Maldives on July 13 and then to Singapore, where he announced his resignation after months of protests over Sri Lanka's economic meltdown.

SHARE
Story Saved
×
Saved Articles
Following
My Reads
Sign out
New Delhi 0C
Thursday, August 11, 2022
Start 15 Days Free Trial Subscribe Now